Global Deep Brain Stimulation in Parkinson\'s Disease market cagr 9.7%

Page 1


Deep Brain Stimulation in Parkinson\'s Disease Market

Deep Brain Stimulation in Parkinson\'s Disease

Market Scope: Industry Analysis, Market Size,

Growth, Trends Till 2031

Request Sample Report

Deep Brain Stimulation in Parkinson\'s Disease Market

Size and Growth

The Deep Brain Stimulation (DBS) market for Parkinson's Disease is expanding rapidly, valued at approximately $1.5 billion in 2023. Key market drivers include rising prevalence of Parkinson’s, technological advancements, and increasing awareness of DBS benefits. Competitive dynamics and evolving patient demographics are shaping market opportunities and growth trajectories in the coming years.

Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Abbott

◍ Aleva Neurotherapeutics SA

◍ Beijing PINS Medical Co

◍ Boston Scientific Corporation

◍ Functional Neuromodulation Ltd

◍ Medtronic

◍ Neuronetics Inc.

◍ NeuroPace Inc.

◍ Nevro Corporation

The Deep Brain Stimulation market for Parkinson's disease features key players like Abbott, Medtronic, and Boston Scientific, offering innovative devices to enhance patient outcomes. Companies drive market growth through R&D, strategic partnerships, and improved therapies. Sales revenue from Medtronic topped $30 billion, while Boston Scientific reached approximately $10 billion. Request Sample Report

Market Segmentation

By Application

Hospitals ◍ Neurology Clinics ◍ Research Centers

By Product

◍ Dual Channel Deep brain Stimulator

Single Channel Deep brain Stimulator

Request Sample Report

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.